Imagine the
Future Possibilities.
About Pulmair
At Pulmair Medical, we are dedicated to transforming the lives of those affected by COPD/Emphysema. As a leader in medical innovation, we specialize in developing advanced, clinically proven therapies designed to offer better and safer treatment for people living with this condition.
Our mission is to transform the lives of those affected by COPD/Emphysema by providing innovative solutions that help them breathe easier and live longer, healthier lives. We are dedicated to advancing the field of pulmonology through tailored treatments that address the unique needs of emphysema patients around the world.
Our Approach
We understand the urgent need for more effective treatments for COPD/Emphysema. Our approach is focused on delivering a safer, more impactful lung volume reduction solution that directly addresses the critical challenges patients face. We aim to:
Reduce Lung Hyperinflation: release trapped air from the lungs, helping improve airflow and overall lung function.
Improve Breathing Function: prevent the collapse of damaged airways during exhalation.
Provide Gentle, Targeted Treatment: reduce lung volume for a broader range of patients without harming healthy lung tissue or causing unwanted side effects.
Implantable Artificial Bronchus (IAB)
The IAB shape and design promote airflow.
The IAB prevents bronchial airway collapse and promotes airflow out of the lung.
The IAB is malleable and compressible for placement in the lung.
The IAB does not sacrifice healthy tissue to achieve lung volume reduction.
Our Therapy
“We founded Pulmair with the goal of treating a very wide range of emphysema patients. We are focused on delivering quality of life to this population and committed to providing a safe and effective product.”
— MARCELO G. LIMA, Chairman, President & CEO
